Engineered Pericyte‐Targeted Extracellular Vesicles Protect Against Hypoperfusion‐Induced Cognitive Impairment and Vascular Demyelination
Journal of Extracellular Vesicles · 2026-06 · 15 (6)
DOI: 10.1002/jev2.70319 ↗Abstract
ABSTRACT Pericyte dysfunction is an early hallmark of vascular cognitive impairment (VCI), yet targeted therapies remain limited. Here, we develop a bio‐orthogonal approach to engineer extracellular vesicles (EVs) functionalized with cyclic NGR (cNGR) peptides for selective pericytes targeting. The resulting cNGR‐EVs demonstrated efficient targeting of CD13‐expressing brain pericytes both in vitro and in vivo . In a mouse model of chronic cerebral hypoperfusion (bilateral common carotid artery stenosis, BCAS), cNGR‐EVs preserved pericyte contractility, protected against cerebral hypoperfusion, reduced blood‐brain barrier leakage, and attenuated demyelination, leading to improved cognitive performance. Single‐cell RNA sequencing further revealed that cNGR‐EVs attenuated the majority of BCAS‐induced transcriptional changes in pericytes, partially preserved pericyte‐mediated intercellular communication, and normalized downstream neuronal and glial gene expression profiles. These findings underscore cNGR‐EVs as a pericyte‐targeted strategy capable of stabilizing the neurovascular unit, maintaining pericyte function, and preventing cognitive decline and myelin loss, highlighting pericytes as a promising therapeutic target in early VCI treatment.
EUVIMED